Galderma has launched Alastin, its regenerative skincare line, across Japan and key Asia-Pacific markets. Alastin—a peptide-based skincare system designed to support skin recovery post-procedure—represents Galderma's push beyond injectables into the higher-margin, recurring-revenue skincare category.